Biohacking Market Share, Size, Trends, Industry Analysis Report, By Type (Inside and Outside); By Product (Smart Drugs, Sensors, Strains, and Others); By Application (Synthetic Biology, Genetic Engineering, Forensic Science, Diagnosis & Treatment, and Drug Testing); By End Use (Pharmaceutical & Biotechnology Companies, Forensic Laboratories, and Others); By Regions; Segment Forecast, 2020 - 2027

Report Summary

全球生物黑客市场价值12美元,070.25 million in 2019 and is expected to grow at a CAGR of 20.4% during the forecast period. The growth of this market is attributed to the increasing demand for implantable devices such as dermal biosensor tattoos, blood test implants, 3D body printing parts, RFID, and NFC implants that enhance day-to-day life of people. For instance, The Three Square Market (the based U.S. tech firm) had offered their employees to implant a microchip as an option in 2017. This microchip is based on RFID (radio frequency identification) and NFC (Near Field Communication) technology, which helps to unlock the door, pay for the vending machine, unlock their computer system within their office.

此外，一组研究人员发现一缕细菌被遗传修饰成光敏细菌，可用于移植几个身体部位（包括肾脏）以印刷3-D图像。此外，另一种类型的生物发力植入技术皮肤生物传感器纹身已经由一支科学家（慕尼黑技术大学）开发，它适用于皮肤作为纹身。它进入墨水形式，含有三种颜色并通过注射植入。这些传感器监测人体的血糖，蛋白质和pH水平，并通过改变纹身颜色来反应。

In 2017, Elon Musk had announced the Neuralink venture, which is designed as ultra-fine threads. Neuralink implanted into brain to detect neuron activities. Elon Musk has invested USD 100 million for this project and he is planning to start the human trial by second half of 2020, subject to the FDA approval. Currently, numerous research and development have been conducted by the companies to control the crisis and develop new drugs due to the sudden rise in COVID-19 disease across the globe. Therefore, extensive demand for smart devices and drugs across the globe is anticipated to drives the growth of the global market.

Know more about this report:请求样本页面

Industry Dynamics

成长司机
The growing awareness about biohacking and the increasing prevalence of chronic diseases across the globe are the factors driving the global market. For instance, according to the Global Health and Wellness, report-2018, more than 40 percent of patients were diagnosed with cardiovascular condition. Furthermore, biohacking can be used in many applications such as boosting life expectancy and enhancing & optimizing human performance that lead to longevity which in turn drives the market growth.

Moreover, a sharp rise in geriatric population is expected to provide opportunities for the market to grow. For instance, according to the World Health Organization (WHO) 2018 report, over 60 years, the proportion of the world population will become double from 12 to 22%. From the same source, a common disease in older age is a chronic obstructive pulmonary disease, diabetes, depression, and dementia. Also, increasing research and development activities initiated by the government to develop new drugs is the factor propelling market growth. For instance, in 2020, the U.S has spent USD 5.1 billion on Covid-19 medical research.

Biohacking Market Report Scope

The market is primarily segmented on the basis of Type, By Product, By Application, By End-Use, and Geographic Region.

By Type	By Product	By Application	By End Use	By Regions
Inside Outside	聪明的药物 Sensors Strains 其他	合成生物学 Genetic Engineering Forensic Science 诊断与治疗 Drug Testing	Pharmaceutical & Biotechnology Companies Forensic Laboratories 其他	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea) 拉丁美洲(布拉兹il, Mexico, Argentina) MEA (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report:请求样本页面

界面类型

On the basis of type, the global market is bifurcated as inside and outside biohacking. Between these two, outside biohacking holds the maximum market share in this market. This high share is due to its application which is safer and easier than inside biohacking. For instance, taking certain supplements or diet. Nutrigenomics is considered the most popular type of outside biohacking and it helps to understand the role of genetics play in health and disease in detail. Thereby, nutrigenomics helps to reduce the risk of developing disease without affecting the body. On the other hand, inside biohacking is sophisticated and expensive as compared to the outside biohacking.

Insight by Product

在产品的基础上，全球市场包括智能药物，传感器，菌株等。2019年，由于对健康补充剂的需求日益增加，智能药物部门持有最大的市场份额。智能药物被称为认知增强剂，用于改善记忆，执行功能，增强个人的创造力。此外，对儿童的记忆增压补充的需求也在增加。此外，对于压力管理以及提高睡眠质量，对营养密集的饮食的需求如今正在增加。

Insight by Application

Based on application, the global market is segmented into synthetic biology, forensic science, diagnosis & treatment, genetic engineering, and drug testing. Among these, diagnosis & treatment holds the maximum market share due to the increasing prevalence of chronic disease across the globe. On the other hand, drug testing is expected to hold the highest CAGR in the forecast period due to increasing research & development by the company and initiative by the government. For instance, in 2015, an eye drop had been developed using a derivative of chlorophyll found in deep-sea fish by a biohacking lab in California.

最终使用洞察

On the basis of end-use, the global market is segmented into pharmaceutical & biotechnology companies, forensic laboratories. Among these, pharmaceutical &生物技术companies hold the largest market share due to the increasing prevalence of diseases and rising demand for devices for monitoring of the blood sugar level, heart rate, and body movement.

Geographic Overview

Based on the region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and MEA. Among all, North America accounts for the highest market share in the global market due to increasing healthcare expenditure coupled with technologically advanced healthcare infrastructure. On the other hand, most key players such as Apple operating in the North America region such as Canada & the U.S. which is another factor propelling the market growth.

Also, increasing research and development activities by companies to develop new drugs for the treatment of the patient is the factor responsible for heightening market growth in the region. Increasing the prevalence of chronic diseases such as heart disease, cancer, diabetes in North America regions is expected to propel the growth of the market. For instance, according to the American Heart Association report, in 2017, Coronary Heart Disease was the leading cause (approx. 42.6%) of deaths in the US. It includes cardiovascular diseases like diseases of the arteries (2.9%), stroke (17.0%), Heart Failure (9.4%), High Blood Pressure (10.5%), and other cardiovascular diseases (17.6%).

由于既定的医疗保健基础设施，欧洲拥有第二大市场份额。yabo娱乐vip此外，由于迅速改善医疗基础设施，亚太地区预计将在预测期内的最高复合中成长。yabo娱乐vip根据2017年的印度斯坦时报发布的一篇文章，它对印度轻松车库实验室设置令人关切。因为在发展任何危险的病毒/细菌疾病如Covid-19这样的情况下，可能导致危险状态的实验室仍然没有制定。

Competitive insights

The companies operating in the global market are involved in the development of the product, strategic initiative, and regional expansion. For instance, in June 2020, Apple has launched watchOS 7, which is the newest version of the operating system that runs on the Apple watch and used to monitor the sleeping pattern of the patient, which in turn drives the market growth. Some of the major players operating the biohacking market include Thync Global Inc., Apple, HVMN, Inc., Synbiota, Grindhouse Wetware, MoodMetric, THE ODIN, and Fitbit, Inc.